Menu
![logo](https://glenmarkpharma-us.com/wp-content/themes/glenmark_us/assets/images/PDF_Banner.png)
News Feed
Glenmarks consolidated revenue increases by 1.46 percent to Rs. 22,565.90 Mn. for Q2 FY 2017 – 18
Business Highlights for Q2 FY 2017-18
- India Business grew by 5.30% to Rs. 7,106.77 Mn
- US Business decreased by 5.72 % to Rs. 7,270.95 Mn. (USD 113.24 Mn)
- Europe Formulations Business grew by 48.50% to Rs. 2,000.24 Mn
- Rest of World (ROW) Business decreased by 0.69% to Rs. 2,520.93 Mn
- API Business grew by 6.90% to Rs. 2,366.14 Mn